Insider Trading & Ownership - Dorval Allison

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Dorval Allison
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-06-13
Sale
2024-06-17
7:18 pm
PUMA BIOTECHNOLOGY INC.PBYIDorval Allison
Director
11,000$3.3724$37,09633,000
(Direct)
View
2023-11-29
Sale
2023-12-01
4:30 pm
Verve Therapeutics Inc.VERVDorval Allison
Chief Financial Officer
554$11.45$6,3437,810
(Direct)
View
2023-06-13
Sale
2023-06-15
9:01 pm
PUMA BIOTECHNOLOGY INC.PBYIDorval Allison
Director
10,000$3.45$34,50044,000
(Direct)
View
2022-11-29
Sale
2022-12-01
5:00 pm
Verve Therapeutics Inc.VERVDorval Allison
Chief Financial Officer
554$22.1$12,2437,811
(Direct)
View
2021-02-11
Sale
2021-02-16
4:10 pm
Voyager Therapeutics Inc.VYGRDorval Allison
Chief Financial Officer
3,186$7.55$24,05445,894
(Direct)
View
2021-01-12
Sale
2021-01-14
5:57 pm
Voyager Therapeutics Inc.VYGRDorval Allison
Chief Financial Officer
2,942$8.62$25,36049,080
(Direct)
View
2020-01-21
Sale
2020-01-29
5:27 pm
Voyager Therapeutics Inc.VYGRDorval Allison
Chief Financial Officer
3,128$13.36$41,79024,522
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-18
Option Award
2024-06-21
9:17 pm
N/A
N/A
PUMA BIOTECHNOLOGY INC.PBYIDorval Allison
Director
27,000$060,000
(Direct)
View
2024-06-05
Option Award
2024-06-07
6:00 pm
N/A
2034-06-04
Aerovate Therapeutics Inc.AVTEDorval Allison
Director
12,500$012,500
(Direct)
View
2024-02-14
Option Award
2024-02-16
4:30 pm
N/A
2034-02-13
Verve Therapeutics Inc.VERVDorval Allison
Chief Financial Officer
225,000$0225,000
(Direct)
View
2023-11-29
Exercise
2023-12-01
4:30 pm
N/A
N/A
Verve Therapeutics Inc.VERVDorval Allison
Chief Financial Officer
1,875$07,810
(Direct)
View
2023-06-13
Option Award
2023-06-15
9:01 pm
N/A
N/A
PUMA BIOTECHNOLOGY INC.PBYIDorval Allison
Director
27,000$044,000
(Direct)
View
2023-06-06
Option Award
2023-06-08
6:00 pm
N/A
2033-06-05
Aerovate Therapeutics Inc.AVTEDorval Allison
Director
12,500$012,500
(Direct)
View
2023-02-14
Option Award
2023-02-16
5:00 pm
N/A
2033-02-13
Verve Therapeutics Inc.VERVDorval Allison
Chief Financial Officer
182,800$0182,800
(Direct)
View
2022-11-29
Exercise
2022-12-01
5:00 pm
N/A
N/A
Verve Therapeutics Inc.VERVDorval Allison
Chief Financial Officer
1,875$07,811
(Direct)
View
2022-06-21
Option Award
2022-06-22
5:01 pm
N/A
2032-06-20
Aerovate Therapeutics Inc.AVTEDorval Allison
Director
12,500$012,500
(Direct)
View
2022-06-14
Option Award
2022-06-17
4:16 pm
N/A
N/A
PUMA BIOTECHNOLOGY INC.PBYIDorval Allison
Director
27,000$027,000
(Direct)
View
2022-02-11
Option Award
2022-02-15
09:00 am
N/A
2032-02-10
Verve Therapeutics Inc.VERVDorval Allison
Chief Financial Officer
60,000$060,000
(Direct)
View
2021-11-29
Option Award
2021-11-30
4:26 pm
N/A
2031-11-28
Verve Therapeutics Inc.VERVDorval Allison
Chief Financial Officer
142,500$0142,500
(Direct)
View
2021-07-15
Option Award
2021-07-19
4:28 pm
N/A
2031-07-14
Aerovate Therapeutics Inc.AVTEDorval Allison
Director
25,000$025,000
(Direct)
View
2021-07-15
Option Award
2021-07-16
4:46 pm
N/A
2031-07-14
PUMA BIOTECHNOLOGY INC.PBYIDorval Allison
Director
108,721$0108,721
(Direct)
View
2021-03-19
Option Award
2021-03-23
4:10 pm
N/A
N/A
Voyager Therapeutics Inc.VYGRDorval Allison
Chief Financial Officer
30,000$0109,894
(Direct)
View
2021-02-16
Option Award
2021-02-18
4:55 pm
N/A
2031-02-16
Voyager Therapeutics Inc.VYGRDorval Allison
Chief Financial Officer
102,000$0147,894
(Direct)
View
2020-02-10
Option Award
2020-02-12
6:21 pm
N/A
2030-02-10
Voyager Therapeutics Inc.VYGRDorval Allison
Chief Financial Officer
82,500$0107,022
(Direct)
View